Reuters logo
BRIEF-Fitch says price debate could realign U.S. drug industries
February 8, 2017 / 6:24 PM / 9 months ago

BRIEF-Fitch says price debate could realign U.S. drug industries

Feb 8 (Reuters) - Fitch:

* Price debate could realign U.S. drug industries

* Fitch says “transition to Trump administration has complicated an ongoing debate about what can and should be done to rein in high cost of pharmaceuticals in U.S.” Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below